Italia markets close in 2 hours 25 minutes

GENE Sep 2024 2.500 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,95000,0000 (0,00%)
In data: 12:33PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,9500
Aperto0,8500
Denaro0,0000
Lettera0,0000
Prezzo d'esercizio2,50
Scadenza2024-09-20
Min-Max giorno0,8500 - 0,9500
Contratto - Min-MaxN/D
Volume11
Open Interest10
  • GlobeNewswire

    GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital Network

    GeneType and Gold Coast Hospital Simon Morriss - Genetic Technologies Ltd CEO and Michelle Ferrari Cestari - Gold Coast Hospital Research Manager GTG CEO, Simon Morriss, is pleased to announce collaboration with Gold Coast Hospital Simon Morriss, Genetic Technologies CEO's Statement MELBOURNE, Australia, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) – a global leader in genomics-based tests in health, wellness and serious disease is pl

  • GlobeNewswire

    Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release

    Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) Expands Reach of Revolutionary geneType Multi-Risk Test in Australia: A major advancement towards preventative Healthcare MELBOURNE, Australia, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (GTG), a pioneering global leader in genomics-based tests focused on health, wellness, and the battle against serious diseases, proudly announces a groundbreaking development. The expanded geneType Multi-Risk Test is now readily accessibl

  • GlobeNewswire

    Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV

    MELBOURNE, Australia, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline driven genomics-based tests in health, wellness and serious disease is pleased to advise that RedChip Companies will air interviews with Genetic Technologies Limited (Nasdaq: GENE) and 60 Degrees Pharmaceuticals (60P) (NASDAQ: SXTP) on The RedChip Money Report®, a sponsored program on Bloomberg TV, this Saturday, September 2, at 7 p.m. Eas